Table 3 The results of univariate analysis.

From: Inverse relationship between LDL-C/HDL-C ratio and atrial fibrillation in chronic kidney disease patients

Variable

Statistics

OR (95%CI)

P-value

Age (years)

60.89 ± 10.05

1.08 (1.06, 1.09)

 < 0.0001

Gender (%)

 Male

16,857 (79.93%)

Ref

 

 Female

4234 (20.07%)

0.71 (0.49, 1.04)

0.0750

Smoke (%)

 No

13,417 (63.61%)

Ref

 

 Yes

7674 (36.39%)

0.69 (0.51, 0.93)

0.0164

Alcohol intake (%)

 No

14,183 (67.25%)

Ref

 

 Yes

6908 (32.75%)

0.74 (0.54, 1.01)

0.0542

Education (%)

  ≤ 9 years

18,217 (86.37%)

Ref

 

  > 9 years

2874 (13.63%)

0.70 (0.44, 1.10)

0.1199

MI (%)

 No

20,441 (96.92%)

Ref

 

 Yes

650 (3.08%)

1.57 (0.83, 2.98)

0.1651

PAD (%)

 No

20,575 (97.55%)

Ref

 

 Yes

516 (2.45%)

1.37 (0.64, 2.93)

0.4124

Hypertension (%)

 No

16,168 (76.66%)

Ref

 

 Yes

4923 (23.34%)

1.31 (0.97, 1.77)

0.0796

DM (%)

 No

19,215 (91.11%)

Ref

 

 Yes

1876 (8.89%)

1.13 (0.72, 1.78)

0.5877

SBP (mmHg)

139.48 ± 22.37

1.01 (1.00, 1.01)

0.0347

DBP (mmHg)

86.93 ± 12.25

1.01 (1.00, 1.02)

0.0195

WC (cm)

88.10 ± 9.97

1.03 (1.02, 1.04)

 < 0.0001

HDL-C (mmol/L)

2.03 ± 0.21

0.59 (0.17, 2.01)

0.3994

LDL-C/HDL-C ratio

1.39 ± 0.35

0.39 (0.25, 0.61)

 < 0.0001

TG (mmol/L)

1.71 ± 1.48

0.80 (0.69, 0.93)

0.0037

TC (mmol/L)

5.06 ± 0.98

0.69 (0.59, 0.80)

 < 0.0001

CRP (mg/L)

3.80 ± 6.53

1.01 (1.00, 1.03)

0.0895

Proteinuria (%)

 No

10,011 (47.47%)

Ref

 

 Yes

11,080 (52.53%)

1.43 (1.08, 1.88)

0.0123

eGFR (mL/min/1.73 m2)

67.23 ± 20.22

1.00 (0.99, 1.01)

0.7074

LDL-C (mmol/L)

2.81 ± 0.69

0.60 (0.47, 0.75)

 < 0.0001

  1. Values are n (%) or mean ± SD or median (quartile).
  2. SBP systolic blood pressure; DBP diastolic blood pressure; WC waist circumference; HDL-C high-density lipoprotein cholesterol; LDL-C/HDL-C ratio low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio; TG triglyceride; TC total cholesterol; CRP C-reactive protein; eGFR evaluated glomerular filtration rate; MI myocardial infarction; PAD peripheral artery disease; DM diabetes; AF atrial fibrillation.